Reply to letter to the editor: Successful eradication of HCV by short-course DAAs in HCV positive donor to HCV-Negative recipient during Haplo-HSCT

Huang C.-F.JIA-HORNG KAO2021-09-042021-09-0420200929-6646https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086929263&doi=10.1016%2fj.jfma.2020.06.009&partnerID=40&md5=9262615d5fd020bbb1e453c5d690b29ehttps://scholars.lib.ntu.edu.tw/handle/123456789/581731[SDGs]SDG3antivirus agent; interferon; peginterferon; ribavirin; sofosbuvir plus velpatasvir; virus RNA; adult; antiviral therapy; combination drug therapy; deceased donor; haploidentical donor; haploidentical transplantation; hematopoietic stem cell transplantation; hepatitis C; human; Letter; nonhuman; short course therapy; viral clearance; virus replication; consensus; hepatitis C; population; Taiwan; Consensus; Hematopoietic Stem Cell Transplantation; Hepatitis C; Humans; Population; TaiwanReply to letter to the editor: Successful eradication of HCV by short-course DAAs in HCV positive donor to HCV-Negative recipient during Haplo-HSCTletter10.1016/j.jfma.2020.06.009325325392-s2.0-85086929263